Travel ETFs Climb on Hopes of Merck’s Oral COVID-19 Drug
October 01, 2021 at 15:53 PM EDT
Travel stocks and sector-related exchange traded funds surged on Friday after Merck revealed promising results for its oral COVID-19 drug. Among the best performing non-leveraged ETFs of Friday, the U.S. Global Jets ETF (NYSEArca: JETS) advanced 5.6%, the AdvisorShares Hotel ETF (BEDZ) increased...
